TALIS BIOMEDICAL CORP - COM NEW (TLIS)

CUSIP: 87424L207

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -14
Total reported value: $0
Price per share: $1.40
Number of holders: 0
Value change: -$26
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 87424L207?
CUSIP 87424L207 identifies TLIS - TALIS BIOMEDICAL CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2024

Recent filing periods for CUSIP 87424L207:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

There are no holders of TLIS - TALIS BIOMEDICAL CORP - COM NEW as of Q1 2025.